4 in 10 Canadians Surveyed Support Mandatory Random COVID-19 Testing
It appears that the majority of Canadians are not in favour of random required testing for COVID-19. A Statistics Canada
Read more
Coronavirus
Statcan Estimates July Manufacturing Sales Increase of 8.7%
Statistics Canada this morning released its flash sheet estimate for July’s manufacturing figures, releasing a manufacturing estimate of 8.7% for
Read more
Relay Medical Forms Joint Venture To Provide COVID-19 Pandemic Response Tech
Relay Medical Corp (CSE: RELA) has formed a joint venture with that of Fio Corp focused on accelerating a COVID-19
Read more
Coronavirus Pandemic Could Wipe Out Up To $30 Trillion from the Global Economy: McKinsey Global Institute
If production disruptions last for a span of at least 100 days amid the coronavirus pandemic, it could cost the
Read more
Revive Therapeutics Signs MOU With Attwill Medical, Manufacturer For Vaxart, For Phase 3 Clinical Trials
Revive Therapeutics (CSE: RVV) (OTC: RVVTF) is one step closer to conducting its phase 3 clinical trials for the use
Read more
Datametrex Secures Rights To Sell And Distribute Rapid COVID-19 Antigen Test Kits
Datametrex AI (TSXV: DM) this morning announced that it has secured the rights to sell and distribute a rapid antigen
Read more
Record Number of Americans Quitting Their Jobs as Fears Over Coronavirus Infections Mount
As the US Bureau of Labour Statistics released its latest Job Openings and Labour turnover Survey (JOLTS)-,which already came in
Read more
Canada’s Federal Government Allocates $3.3 Billion Towards Pandemic Resistant Infrastructure
The Liberal government has made available a total of $3.3 billion in funds for provinces and territories in order to
Read more
Canadian Companies Face Uncertainty: 14% of Small Businesses at Risk of Bankruptcy Due to COVID-19
As many provinces across Canada are well underway in their recovery plans, it appears that some sectors are facing even
Read more
Revive Announces Timeline For Phase 3 Studies, Sees Beneficial Psilocybin Developments
Revive Therapeutics (CSE: RVV) this morning announced that on the heels of receiving FDA approval for phase 3 clinical trials
Read more